Immunogenicity and safety of a hexavalent pediatric vaccine in HIVexposed infected and uninfected infants in Republic of South Africa

dc.citation.doi10.1080/21645515.2020.1839289
dc.citation.epage1778
dc.citation.spage1770
dc.contributor.authorAnthonet Koen
dc.contributor.authorShabir Madhi
dc.contributor.authorOlga Lyabis
dc.contributor.authorEmmanuel Vidor
dc.contributor.authorBeverley Cowper
dc.contributor.authorThinus Marais
dc.contributor.authorA Et Al
dc.date.accessioned2023-05-04T08:48:52Z
dc.date.available2023-05-04T08:48:52Z
dc.identifier.citationSCOPUS
dc.identifier.issn21645515
dc.identifier.urihttps://hdl.handle.net/10539/35340
dc.journal.titleHUMAN VACCINES AND IMMUNOTHERAPEUTICS
dc.journal.volume17
dc.titleImmunogenicity and safety of a hexavalent pediatric vaccine in HIVexposed infected and uninfected infants in Republic of South Africa
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal.pdf
Size:
596.24 KB
Format:
Adobe Portable Document Format
Description:
Journal